论文部分内容阅读
2010年6月14日,《柳叶刀·肿瘤学》在线发表了一项大型荟萃分析结果,分析表明,使用血管紧张素Ⅱ受体拮抗剂(ARB)与新发生癌症危险轻度增加相关[1]。
On June 14, 2010, Lancet Oncology published a large meta-analysis online that showed that the use of angiotensin II receptor blocker (ARB) was associated with a modest increase in the risk of developing new cancers [ 1].